PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis
Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.469
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV
Available in full text
November 1, 2011
Elsevier BV